




Searching News Database: stem cell
Your search returned too many results! The most recent 500 items are shown below:
HSMN NewsFeed - 26 Nov 2024
Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc.
Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc.
HSMN NewsFeed - 22 Nov 2024
U.S. FDA Approves StemCyte Biologics License Application for REGENECYTE(TM) Cord Blood Cell Therapy Product
U.S. FDA Approves StemCyte Biologics License Application for REGENECYTE(TM) Cord Blood Cell Therapy Product
HSMN NewsFeed - 26 Jun 2024
BrainStorm Cell Therapeutics Reaches Alignment with FDA on CMC Aspects of Phase 3b NurOwn(R) Clinical Trial
BrainStorm Cell Therapeutics Reaches Alignment with FDA on CMC Aspects of Phase 3b NurOwn(R) Clinical Trial
HSMN NewsFeed - 20 Jun 2024
BrainStorm Cell Therapeutics Announces Appointment of Haro Hartounian Ph.D. as Chief Operating Officer
BrainStorm Cell Therapeutics Announces Appointment of Haro Hartounian Ph.D. as Chief Operating Officer
HSMN NewsFeed - 14 Feb 2024
Dr. Lisa Johnson-Pratt Joins Aspen Neuroscience as Senior Vice President, Therapeutic Program Lead
Dr. Lisa Johnson-Pratt Joins Aspen Neuroscience as Senior Vice President, Therapeutic Program Lead
HSMN NewsFeed - 24 Oct 2023
BrainStorm Cell Therapeutics Announces Strategic Realignment Prioritizing NurOwn(R) for the Treatment of ALS
BrainStorm Cell Therapeutics Announces Strategic Realignment Prioritizing NurOwn(R) for the Treatment of ALS
HSMN NewsFeed - 4 Jan 2023
Monica Shaw appointed CEO of Oncopeptides - Jakob Lindberg assumes position as Chief Scientific Officer
Monica Shaw appointed CEO of Oncopeptides - Jakob Lindberg assumes position as Chief Scientific Officer
HSMN NewsFeed - 27 Dec 2022
BrainStorm Cell Therapeutics Announces Type A Meeting with FDA Granted for NurOwn(R)
BrainStorm Cell Therapeutics Announces Type A Meeting with FDA Granted for NurOwn(R)
HSMN NewsFeed - 29 Jun 2022
Artax Biopharma Appoints D. Scott Batty, Jr., M.D. as Chief Medical Officer
Artax Biopharma Appoints D. Scott Batty, Jr., M.D. as Chief Medical Officer
HSMN NewsFeed - 13 Jun 2022
STRM.BIO Appoints Vanessa Salazar as Vice President of Business Development
STRM.BIO Appoints Vanessa Salazar as Vice President of Business Development
HSMN NewsFeed - 9 Nov 2021
Industry Veteran Kameel Farag Joins Aspen Neuroscience as Chief Financial Officer
Industry Veteran Kameel Farag Joins Aspen Neuroscience as Chief Financial Officer
HSMN NewsFeed - 8 Nov 2021
BrainStorm Cell Therapeutics Expands Leadership Team to Support Clinical Development and Medical Affairs
BrainStorm Cell Therapeutics Expands Leadership Team to Support Clinical Development and Medical Affairs
HSMN NewsFeed - 13 Sep 2021
ViaCyte Appoints Stem Cell Therapy Expert Dr. Timothy Kieffer as Chief Scientific Officer
ViaCyte Appoints Stem Cell Therapy Expert Dr. Timothy Kieffer as Chief Scientific Officer
HSMN NewsFeed - 13 Jul 2021
Regulatory Affairs Expert Ana Sousa Joins Aspen Neuroscience as Senior Vice President
Regulatory Affairs Expert Ana Sousa Joins Aspen Neuroscience as Senior Vice President
HSMN NewsFeed - 13 Jul 2021
Prime Medicine Launches with $315 Million Financing to Deliver on the Promise of Prime Editing
Prime Medicine Launches with $315 Million Financing to Deliver on the Promise of Prime Editing
HSMN NewsFeed - 14 May 2021
FDA Responds to Creative Medical Technology Holdings Regarding Its ImmCelz(R) IND for Stroke Treatment
FDA Responds to Creative Medical Technology Holdings Regarding Its ImmCelz(R) IND for Stroke Treatment
HSMN NewsFeed - 11 May 2021
Appia Bio Launches With $52 Million Series A Financing and Establishes Scientific Advisory Board
Appia Bio Launches With $52 Million Series A Financing and Establishes Scientific Advisory Board
HSMN NewsFeed - 26 Mar 2021
European Medicines Agency Accepts Marketing Authorization Application for Enfortumab Vedotin
European Medicines Agency Accepts Marketing Authorization Application for Enfortumab Vedotin
HSMN NewsFeed - 23 Mar 2021
Poseida Therapeutics Announces Carl June, M.D., to Chair Immuno-Oncology Scientific Advisory Board
Poseida Therapeutics Announces Carl June, M.D., to Chair Immuno-Oncology Scientific Advisory Board
HSMN NewsFeed - 3 Mar 2021
Creative Medical Technology Holdings Provides Update on ImmCelz(R) FDA Application
Creative Medical Technology Holdings Provides Update on ImmCelz(R) FDA Application
HSMN NewsFeed - 16 Feb 2021
Akan Biosciences Announces FDA Acceptance of IND Application for StroMel(TM) in Osteoarthritis of Knee
Akan Biosciences Announces FDA Acceptance of IND Application for StroMel(TM) in Osteoarthritis of Knee
HSMN NewsFeed - 1 Dec 2020
Actinium Appoints Mary Mei Chen, M.D., Ph.D. as Vice President of Clinical Development
Actinium Appoints Mary Mei Chen, M.D., Ph.D. as Vice President of Clinical Development
HSMN NewsFeed - 23 Nov 2020
BrainStorm to present NurOwn(R) Phase 3 Clinical Trial Results at 31st International Symposium on ALS/MND
BrainStorm to present NurOwn(R) Phase 3 Clinical Trial Results at 31st International Symposium on ALS/MND
HSMN NewsFeed - 17 Nov 2020
Celularity Announces Appointments of Chief Medical Officer and Senior Vice President of Regulatory Affairs
Celularity Announces Appointments of Chief Medical Officer and Senior Vice President of Regulatory Affairs
HSMN NewsFeed - 18 Sep 2020
BrainCool Announces Statistically Significant Late-Breaking Clinical Data at ESMO Virtual Congress 2020
BrainCool Announces Statistically Significant Late-Breaking Clinical Data at ESMO Virtual Congress 2020
HSMN NewsFeed - 24 Jun 2020
BrainStorm Expands Clinical Pipeline to Evaluate NurOwn(R) for the Treatment of Alzheimer's Disease
BrainStorm Expands Clinical Pipeline to Evaluate NurOwn(R) for the Treatment of Alzheimer's Disease
HSMN NewsFeed - 24 Apr 2020
Japan Grants Patent for Intralymphatic Administration of the Diabetes Vaccine Diamyd(R)
Japan Grants Patent for Intralymphatic Administration of the Diabetes Vaccine Diamyd(R)
HSMN NewsFeed - 25 Feb 2020
EmCyte Announces FDA 510(k) Clearance for its PurePRP(R) Supraphysiologic Concentrating System
EmCyte Announces FDA 510(k) Clearance for its PurePRP(R) Supraphysiologic Concentrating System
HSMN NewsFeed - 12 Feb 2020
Regenexx, First to Use Stem Cells in Orthopedic Therapy, Marks 15th Anniversary
Regenexx, First to Use Stem Cells in Orthopedic Therapy, Marks 15th Anniversary
HSMN NewsFeed - 7 Jan 2020
IFM Therapeutics Appoints Michael Cooke, Ph.D., as Chief Scientific Officer
IFM Therapeutics Appoints Michael Cooke, Ph.D., as Chief Scientific Officer
HSMN NewsFeed - 6 Jan 2020
CARsgen Appoints Yong Fan as Senior Vice President of Global Regulatory Affairs
CARsgen Appoints Yong Fan as Senior Vice President of Global Regulatory Affairs
HSMN NewsFeed - 16 Dec 2019
Anixa Biosciences Announces Commercial Launch of Cchek(TM) Prostate Cancer Confirmatory Test
Anixa Biosciences Announces Commercial Launch of Cchek(TM) Prostate Cancer Confirmatory Test
HSMN NewsFeed - 22 Nov 2019
Anixa Biosciences Announces Collaboration with Urology Centers of Alabama on Cchek(TM) Prostate Cancer Study
Anixa Biosciences Announces Collaboration with Urology Centers of Alabama on Cchek(TM) Prostate Cancer Study
HSMN NewsFeed - 29 Aug 2019
AbbVie Discontinues Rovalpituzumab Tesirine (Rova-T) Research and Development Program
AbbVie Discontinues Rovalpituzumab Tesirine (Rova-T) Research and Development Program
HSMN NewsFeed - 12 Aug 2019
CASI Pharmaceuticals Announces Launch of EVOMELA(R) (melphalan for injection) in China
CASI Pharmaceuticals Announces Launch of EVOMELA(R) (melphalan for injection) in China
HSMN NewsFeed - 8 Aug 2019
Bayer Acquires Bluerock Therapeutics to Build Leading Position in Cell Therapy
Bayer Acquires Bluerock Therapeutics to Build Leading Position in Cell Therapy
HSMN NewsFeed - 24 Jun 2019
BioEclipse Therapeutics(TM) Announces Appointment of New Directors and Series A-1 Financing
BioEclipse Therapeutics(TM) Announces Appointment of New Directors and Series A-1 Financing
HSMN NewsFeed - 28 Jan 2019
First-In-Human Case Using Biostage's Bioengineered Esophageal Implant is Presented at Major Surgical Meeting
First-In-Human Case Using Biostage's Bioengineered Esophageal Implant is Presented at Major Surgical Meeting
HSMN NewsFeed - 29 Nov 2018
ViaCyte Secures $80 Million Financing to Advance Functional Cures for Insulin-Requiring Diabetes
ViaCyte Secures $80 Million Financing to Advance Functional Cures for Insulin-Requiring Diabetes
HSMN NewsFeed - 28 Nov 2018
Generex Biotechnology Expands Medical Device Portfolio With Acquisition of Olaregen Therapeutix Inc.
Generex Biotechnology Expands Medical Device Portfolio With Acquisition of Olaregen Therapeutix Inc.
HSMN NewsFeed - 26 Nov 2018
BlueRock Therapeutics Appoints Min Wang, J.D., Ph.D., as Chief Legal and Administrative Officer
BlueRock Therapeutics Appoints Min Wang, J.D., Ph.D., as Chief Legal and Administrative Officer
HSMN NewsFeed - 8 Nov 2018
Mr. Matthew Dallas and Mr. Jeffrey Young Appointed to Biostage Board of Directors
Mr. Matthew Dallas and Mr. Jeffrey Young Appointed to Biostage Board of Directors
HSMN NewsFeed - 18 Oct 2018
PolarityTE(R) Announces Former Acelity Leader Sharon Whalen as Vice President of Market Access
PolarityTE(R) Announces Former Acelity Leader Sharon Whalen as Vice President of Market Access
HSMN NewsFeed - 20 Sep 2018
BlueRock Therapeutics Appoints Shane Kovacs as Chief Business and Financial Officer
BlueRock Therapeutics Appoints Shane Kovacs as Chief Business and Financial Officer
HSMN NewsFeed - 31 Jul 2018
Natera Appoints Roy Baynes to Board of Directors, Adding Deep Oncology Experience
Natera Appoints Roy Baynes to Board of Directors, Adding Deep Oncology Experience
HSMN NewsFeed - 12 Jun 2018
NuVasive Launches AttraX Scaffold Biologic And Reports First Clinical Use
NuVasive Launches AttraX Scaffold Biologic And Reports First Clinical Use
HSMN NewsFeed - 1 Jun 2018
Fortuna Fix Announces Appointment of Madhavan Balachandran to Board of Directors
Fortuna Fix Announces Appointment of Madhavan Balachandran to Board of Directors
HSMN NewsFeed - 30 May 2018
FDA expedites review of Novartis drug Promacta(R) for first-line severe aplastic anemia (SAA)
FDA expedites review of Novartis drug Promacta(R) for first-line severe aplastic anemia (SAA)
HSMN NewsFeed - 8 Mar 2018
BrainStorm Announces Operational Highlights and Financial Results for the Year Ended December 31, 2017
BrainStorm Announces Operational Highlights and Financial Results for the Year Ended December 31, 2017
HSMN NewsFeed - 27 Feb 2018
Amgen Receives Positive CHMP Opinion For Delivery System Of Neulasta(R) (pegfilgrastim)
Amgen Receives Positive CHMP Opinion For Delivery System Of Neulasta(R) (pegfilgrastim)
HSMN NewsFeed - 16 Jan 2018
RXi Pharmaceuticals Announces Business Strategy to Focus on Immuno-Oncology Programs to Accelerate Growth
RXi Pharmaceuticals Announces Business Strategy to Focus on Immuno-Oncology Programs to Accelerate Growth
HSMN NewsFeed - 2 Nov 2017
BrainStorm Strengthens Executive Team: Appoints Eyal Rubin as Chief Financial Officer
BrainStorm Strengthens Executive Team: Appoints Eyal Rubin as Chief Financial Officer
HSMN NewsFeed - 5 Sep 2017
FDA Grants Orphan Drug Status to Cellect's ApoGraft(TM) for Acute GvHD and Chronic GvHD
FDA Grants Orphan Drug Status to Cellect's ApoGraft(TM) for Acute GvHD and Chronic GvHD
HSMN NewsFeed - 28 Aug 2017
CSL Behring to Acquire Biotech Company Calimmune and its Proprietary Stem Cell Gene Therapy Platform
CSL Behring to Acquire Biotech Company Calimmune and its Proprietary Stem Cell Gene Therapy Platform
HSMN NewsFeed - 17 Aug 2017
BlueRock Therapeutics Expands Toronto Presence with R&D and Manufacturing Hub, Appoints Key R&D Leadership
BlueRock Therapeutics Expands Toronto Presence with R&D and Manufacturing Hub, Appoints Key R&D Leadership
HSMN NewsFeed - 7 Aug 2017
Biostage Announces the Use of Its Esophageal Implant Product Candidate in a Patient
Biostage Announces the Use of Its Esophageal Implant Product Candidate in a Patient
HSMN NewsFeed - 17 Jul 2017
Phoenix Molecular Designs Appoints Leading Oncology Expert Dr. Gerrit Los as Chief Scientific Officer
Phoenix Molecular Designs Appoints Leading Oncology Expert Dr. Gerrit Los as Chief Scientific Officer
HSMN NewsFeed - 12 Jul 2017
Asterias Biotherapeutics Completes Enrollment and Dosing of SCiStar Study's AIS-B 10 Million Cell Cohort
Asterias Biotherapeutics Completes Enrollment and Dosing of SCiStar Study's AIS-B 10 Million Cell Cohort
HSMN NewsFeed - 6 Jul 2017
Regenerating Knee Cartilage with Stem Cells: Groundbreaking Clinical Trial Underway at Andrews Institute
Regenerating Knee Cartilage with Stem Cells: Groundbreaking Clinical Trial Underway at Andrews Institute
HSMN NewsFeed - 30 May 2017
Array BioPharma and Bristol-Myers Squibb Announce Strategic Collaboration
Array BioPharma and Bristol-Myers Squibb Announce Strategic Collaboration
HSMN NewsFeed - 17 Apr 2017
OncoMed’s Phase 2 Trial of Tarextumab in Small Cell Lung Cancer Does Not Meet Endpoints
OncoMed’s Phase 2 Trial of Tarextumab in Small Cell Lung Cancer Does Not Meet Endpoints
HSMN NewsFeed - 27 Mar 2017
Dinutuximab beta receives positive recommendation for the treatment of high-risk neuroblastoma in Europe
Dinutuximab beta receives positive recommendation for the treatment of high-risk neuroblastoma in Europe
HSMN NewsFeed - 13 Mar 2017
Lycera Announces the Appointment of Pablo J. Cagnoni, M.D., to the Board of Directors
Lycera Announces the Appointment of Pablo J. Cagnoni, M.D., to the Board of Directors
HSMN NewsFeed - 8 Mar 2017
AzurRx Announces Addition of Charles J Casamento to the Board of Directors
AzurRx Announces Addition of Charles J Casamento to the Board of Directors
HSMN NewsFeed - 22 Feb 2017
Symbiomix Therapeutics Appoints David L. Stern as Chief Executive Officer
Symbiomix Therapeutics Appoints David L. Stern as Chief Executive Officer
HSMN NewsFeed - 20 Jan 2017
Bristol-Myers Squibb Provides Regulatory Update in First-line Lung Cancer
Bristol-Myers Squibb Provides Regulatory Update in First-line Lung Cancer
HSMN NewsFeed - 13 Dec 2016
Creative Medical Technology Holdings Files Patent on AmnioStem Stroke Therapy
Creative Medical Technology Holdings Files Patent on AmnioStem Stroke Therapy
HSMN NewsFeed - 28 Nov 2016
Conditional Approval from the European Commission to Treat Multiple Myeloma
Conditional Approval from the European Commission to Treat Multiple Myeloma
HSMN NewsFeed - 14 Nov 2016
Boston Biomedical Announces Orphan Drug Designation for Napabucasin in Pancreatic Cancer
Boston Biomedical Announces Orphan Drug Designation for Napabucasin in Pancreatic Cancer
HSMN NewsFeed - 26 Oct 2016
Actinium Pharmaceuticals Announces New Hires As Supply Chain Organization Expands To Accommodate Growth
Actinium Pharmaceuticals Announces New Hires As Supply Chain Organization Expands To Accommodate Growth
HSMN NewsFeed - 7 Oct 2016
Osiris Therapeutics Announces Appointment of Alberto Avendano, M.D. as Chief Medical Officer
Osiris Therapeutics Announces Appointment of Alberto Avendano, M.D. as Chief Medical Officer
HSMN NewsFeed - 20 Jul 2016
Cellectar Biosciences Appoints Jarrod Longcor Senior Vice President of Corporate Development and Operations
Cellectar Biosciences Appoints Jarrod Longcor Senior Vice President of Corporate Development and Operations
HSMN NewsFeed - 12 Jul 2016
AMAG Pharmaceuticals Appoints Mark Stanton as Vice President, Market Access & Corporate Accounts
AMAG Pharmaceuticals Appoints Mark Stanton as Vice President, Market Access & Corporate Accounts
HSMN NewsFeed - 29 Jun 2016
Biostage Files for FDA Orphan Drug Designation for Cellspan(TM) Esophageal Implant
Biostage Files for FDA Orphan Drug Designation for Cellspan(TM) Esophageal Implant
HSMN NewsFeed - 28 Jun 2016
FDA Grants Priority Review for Genentech’s OCREVUS(TM) (ocrelizumab) Biologics License Application
FDA Grants Priority Review for Genentech’s OCREVUS(TM) (ocrelizumab) Biologics License Application
HSMN NewsFeed - 10 Jun 2016
AiVita Biomedical Raises $2m in Series A Financing for Commercial and Clinical-Stage Program Development
AiVita Biomedical Raises $2m in Series A Financing for Commercial and Clinical-Stage Program Development
HSMN NewsFeed - 25 May 2016
Roche announces the first FDA-approved CMV test for use in hematopoietic stem cell transplant recipients
Roche announces the first FDA-approved CMV test for use in hematopoietic stem cell transplant recipients
HSMN NewsFeed - 20 May 2016
Neuralstem Announces Plan of Reorganization to Further Align Business with Strategic Intent
Neuralstem Announces Plan of Reorganization to Further Align Business with Strategic Intent
HSMN NewsFeed - 4 Apr 2016
BioLineRx's Novel Treatment for Non-Surgical Removal of Skin Lesions Receives CE Mark Approval
BioLineRx's Novel Treatment for Non-Surgical Removal of Skin Lesions Receives CE Mark Approval
HSMN NewsFeed - 29 Feb 2016
Asterias Biotherapeutics Appoints Stephen L. Cartt President and Chief Executive Officer
Asterias Biotherapeutics Appoints Stephen L. Cartt President and Chief Executive Officer
HSMN NewsFeed - 16 Feb 2016
Neuralstem Appoints Richard Daly as President and Chief Executive Officer
Neuralstem Appoints Richard Daly as President and Chief Executive Officer
HSMN NewsFeed - 25 Jan 2016
BioLineRx Receives Confirmation of Medical Device Classification in Europe for Celiac Treatment
BioLineRx Receives Confirmation of Medical Device Classification in Europe for Celiac Treatment
HSMN NewsFeed - 28 Dec 2015
Chimerix Announces Top-Line Results From Phase 3 SUPPRESS Trial of Brincidofovir
Chimerix Announces Top-Line Results From Phase 3 SUPPRESS Trial of Brincidofovir
HSMN NewsFeed - 11 Nov 2015
Recardio Secures $3 Million in Series A Financing, Relocates Headquarters to San Francisco
Recardio Secures $3 Million in Series A Financing, Relocates Headquarters to San Francisco
HSMN NewsFeed - 4 Nov 2015
Flagship Ventures Launches Evelo Therapeutics To Develop Microbiome Therapies for Cancer
Flagship Ventures Launches Evelo Therapeutics To Develop Microbiome Therapies for Cancer
HSMN NewsFeed - 2 Nov 2015
New CyberKnife(R) and TomoTherapy(R) System Data Presented at Leading Scientific Industry Meeting
New CyberKnife(R) and TomoTherapy(R) System Data Presented at Leading Scientific Industry Meeting
HSMN NewsFeed - 29 Oct 2015
Bellicum Appoints Alan K. Smith as Senior Vice President of Manufacturing
Bellicum Appoints Alan K. Smith as Senior Vice President of Manufacturing
HSMN NewsFeed - 22 Sep 2015
ImmunoCellular Therapeutics Appoints Mark A. Schlossberg and Gregg A. Lapointe to its Board of Directors
ImmunoCellular Therapeutics Appoints Mark A. Schlossberg and Gregg A. Lapointe to its Board of Directors
HSMN NewsFeed - 25 Aug 2015
Panther Biotechnology, Inc. Announces $1.215 Million Financing With Chicago Venture Partners
Panther Biotechnology, Inc. Announces $1.215 Million Financing With Chicago Venture Partners
HSMN NewsFeed - 12 Aug 2015
Japan Grants Safety Clearance to Pluristem's PLX-PAD Cells for Use in Clinical Trials
Japan Grants Safety Clearance to Pluristem's PLX-PAD Cells for Use in Clinical Trials
HSMN NewsFeed - 19 Jul 2015
Sorrento Announces Departure of Mr. George Uy to become CEO of Start-up Company
Sorrento Announces Departure of Mr. George Uy to become CEO of Start-up Company
HSMN NewsFeed - 15 Jul 2015
Fate Therapeutics Appoints Dr. Stewart Abbot as Vice President, Translational Research
Fate Therapeutics Appoints Dr. Stewart Abbot as Vice President, Translational Research
HSMN NewsFeed - 14 Jul 2015
Transgenomic Launches Most Comprehensive Genetic Test for Diagnosis of Leukodystrophy
Transgenomic Launches Most Comprehensive Genetic Test for Diagnosis of Leukodystrophy
HSMN NewsFeed - 16 Jun 2015
Cellectar Appoints Industry Veteran Jim Caruso President and Chief Executive Officer
Cellectar Appoints Industry Veteran Jim Caruso President and Chief Executive Officer
HSMN NewsFeed - 12 Jun 2015
FDA Approves Promacta(R) for New Pediatric Chronic Immune Thrombocytopenia (cITP) Indication
FDA Approves Promacta(R) for New Pediatric Chronic Immune Thrombocytopenia (cITP) Indication
HSMN NewsFeed - 12 Jun 2015
Cesca Therapeutics Board of Directors Appoint Robin C. Stracey as Chief Executive Officer
Cesca Therapeutics Board of Directors Appoint Robin C. Stracey as Chief Executive Officer
HSMN NewsFeed - 13 May 2015
Jeng-Dar Yang Ph.D. Joins Actinium Pharmaceuticals as Vice President of Pharmaceutical Development
Jeng-Dar Yang Ph.D. Joins Actinium Pharmaceuticals as Vice President of Pharmaceutical Development
HSMN NewsFeed - 8 Apr 2015
ArmaGen Announces FDA Acceptance of IND Application for AGT-181 for the Treatment of Hurler Syndrome
ArmaGen Announces FDA Acceptance of IND Application for AGT-181 for the Treatment of Hurler Syndrome
HSMN NewsFeed - 24 Mar 2015
StemCells, Inc. Appoints Ian Massey as President and Chief Operating Officer
StemCells, Inc. Appoints Ian Massey as President and Chief Operating Officer
HSMN NewsFeed - 17 Feb 2015
Regen BioPharma, Inc. Expands Management Team With the Addition of New CFO Todd Caven
Regen BioPharma, Inc. Expands Management Team With the Addition of New CFO Todd Caven
HSMN NewsFeed - 17 Feb 2015
BioRestorative Therapies Announces the Appointment of Edward Field as President of the brtxDISC(TM) Division
BioRestorative Therapies Announces the Appointment of Edward Field as President of the brtxDISC(TM) Division
HSMN NewsFeed - 30 Jan 2015
Calithera Biosciences Appoints Keith Orford, M.D., Ph.D. to Vice President of Clinical Development
Calithera Biosciences Appoints Keith Orford, M.D., Ph.D. to Vice President of Clinical Development
HSMN NewsFeed - 12 Jan 2015
CTI BioPharma Appoints Alan K. Burnett, M.D. As Therapeutic Area Lead, Myeloid Diseases
CTI BioPharma Appoints Alan K. Burnett, M.D. As Therapeutic Area Lead, Myeloid Diseases
HSMN NewsFeed - 4 Nov 2014
BioTime Receives Authorization to Begin Pivotal Human Clinical Trial of Renevia(TM) in Europe
BioTime Receives Authorization to Begin Pivotal Human Clinical Trial of Renevia(TM) in Europe
HSMN NewsFeed - 1 Oct 2014
Cardio3 Biosciences Announces New Business Development Strategy To Broaden Its Product Pipeline
Cardio3 Biosciences Announces New Business Development Strategy To Broaden Its Product Pipeline
HSMN NewsFeed - 27 Aug 2014
Bellicum Pharmaceuticals Secures $55 Million in Oversubscribed Series C Financing
Bellicum Pharmaceuticals Secures $55 Million in Oversubscribed Series C Financing
HSMN NewsFeed - 21 Jul 2014
CorMatrix(R) Reports FDA Clearance of CorMatrix ECM(R) for Vascular Repair
CorMatrix(R) Reports FDA Clearance of CorMatrix ECM(R) for Vascular Repair
HSMN NewsFeed - 14 Apr 2014
Kite Pharma Expands Leadership Team and Announces Senior Management Promotions
Kite Pharma Expands Leadership Team and Announces Senior Management Promotions
HSMN NewsFeed - 26 Mar 2014
Cesca Therapeutics Submits pre-IDE Information Package to FDA for Surgwerks(TM) CLI therapy System
Cesca Therapeutics Submits pre-IDE Information Package to FDA for Surgwerks(TM) CLI therapy System
HSMN NewsFeed - 26 Mar 2014
Osiris Therapeutics Announces Therésa K. Dixon as General Manager of Market Access and Reimbursement
Osiris Therapeutics Announces Therésa K. Dixon as General Manager of Market Access and Reimbursement
HSMN NewsFeed - 25 Mar 2014
BrainStorm and Massachusetts General Hospital Sign Definitive Agreement for ALS Clinical Trial
BrainStorm and Massachusetts General Hospital Sign Definitive Agreement for ALS Clinical Trial
HSMN NewsFeed - 12 Mar 2014
RTI Surgical(TM) Launches Two Natural Bone Grafting Solutions at AAOS Annual Meeting
RTI Surgical(TM) Launches Two Natural Bone Grafting Solutions at AAOS Annual Meeting
HSMN NewsFeed - 3 Mar 2014
BioRestorative Therapies Names Gregory Lutz, M.D. as Chief Medical Advisor for Spine Medicine
BioRestorative Therapies Names Gregory Lutz, M.D. as Chief Medical Advisor for Spine Medicine
HSMN NewsFeed - 12 Feb 2014
Osiris Therapeutics Promotes Frank Czworka to Vice President and General Manager of Wound Care
Osiris Therapeutics Promotes Frank Czworka to Vice President and General Manager of Wound Care
HSMN NewsFeed - 10 Feb 2014
Alliqua Appoints Janice M. Smiell, M.D. as its First Chief Medical Officer
Alliqua Appoints Janice M. Smiell, M.D. as its First Chief Medical Officer
HSMN NewsFeed - 30 Jan 2014
Stem Cell Therapeutics Announces Appointment of Dr. Calvin R. Stiller as Chairman
Stem Cell Therapeutics Announces Appointment of Dr. Calvin R. Stiller as Chairman
HSMN NewsFeed - 29 Jan 2014
Bioheart Announces First Adipose Derived Stem Cell Implantation in Azerbaijan
Bioheart Announces First Adipose Derived Stem Cell Implantation in Azerbaijan
HSMN NewsFeed - 14 Jan 2014
Osiris Therapeutics Board Confirms Lode Debrabandere, PhD, MBA, as President and Chief Executive Officer
Osiris Therapeutics Board Confirms Lode Debrabandere, PhD, MBA, as President and Chief Executive Officer
HSMN NewsFeed - 6 Jan 2014
Fibrocell Science Appoints Robert Sheroff, Vice President of Technical Operations
Fibrocell Science Appoints Robert Sheroff, Vice President of Technical Operations
HSMN NewsFeed - 6 Jan 2014
PIXUVRI(R) (pixantrone) Receives Positive Final Appraisal Determination from NICE
PIXUVRI(R) (pixantrone) Receives Positive Final Appraisal Determination from NICE
HSMN NewsFeed - 19 Dec 2013
ViaCyte Appoints Mark Foletta, former CFO of Amylin, to its Board of Directors
ViaCyte Appoints Mark Foletta, former CFO of Amylin, to its Board of Directors
HSMN NewsFeed - 12 Dec 2013
Advanced Cell Technology Appoints Eddy Anglade M.D. Executive Vice President of Clinical Development
Advanced Cell Technology Appoints Eddy Anglade M.D. Executive Vice President of Clinical Development
HSMN NewsFeed - 4 Dec 2013
Cell Therapeutics and GKV-SV Reach Agreement on Pricing of PIXUVRI(R) (pixantrone) in Germany
Cell Therapeutics and GKV-SV Reach Agreement on Pricing of PIXUVRI(R) (pixantrone) in Germany
HSMN NewsFeed - 18 Nov 2013
Actinium Pharmaceuticals Announces Plans For Iomab(TM)-B Phase 3 Pivotal Trial Following Meeting With FDA
Actinium Pharmaceuticals Announces Plans For Iomab(TM)-B Phase 3 Pivotal Trial Following Meeting With FDA
HSMN NewsFeed - 18 Nov 2013
Kiadis Pharma Provides Positive Update on its Phase II Clinical Program with Blood Cancer Treatment ATIR(TM)
Kiadis Pharma Provides Positive Update on its Phase II Clinical Program with Blood Cancer Treatment ATIR(TM)
HSMN NewsFeed - 25 Oct 2013
Bioheart Announces Agreement With Anosis to Distribute Products in the Middle East
Bioheart Announces Agreement With Anosis to Distribute Products in the Middle East
HSMN NewsFeed - 22 Oct 2013
Gentium Receives Marketing Authorization From the European Commission for Defitelio(R) (Defibrotide)
Gentium Receives Marketing Authorization From the European Commission for Defitelio(R) (Defibrotide)
HSMN NewsFeed - 15 Oct 2013
Second Draft NICE Guidance for Aggressive non-Hodgkin Lymphoma Treatment, PIXUVRI(R) (pixantrone)
Second Draft NICE Guidance for Aggressive non-Hodgkin Lymphoma Treatment, PIXUVRI(R) (pixantrone)
HSMN NewsFeed - 11 Sep 2013
Cardioxyl Pharmaceuticals Appoints Shi Yin Foo, M.D., Ph.D., As Chief Medical Officer
Cardioxyl Pharmaceuticals Appoints Shi Yin Foo, M.D., Ph.D., As Chief Medical Officer
HSMN NewsFeed - 19 Aug 2013
Market Access Granted in France for Aggressive non-Hodgkin Lymphoma Treatment, PIXUVRI(R) (pixantrone)
Market Access Granted in France for Aggressive non-Hodgkin Lymphoma Treatment, PIXUVRI(R) (pixantrone)
HSMN NewsFeed - 24 Jul 2013
Verastem Receives Orphan Drug Designation from the U.S. FDA for Defactinib in Mesothelioma
Verastem Receives Orphan Drug Designation from the U.S. FDA for Defactinib in Mesothelioma
HSMN NewsFeed - 22 Jul 2013
SynGen Hires Former Pall Medical Executive as President of Cord Blood Business Unit
SynGen Hires Former Pall Medical Executive as President of Cord Blood Business Unit
HSMN NewsFeed - 16 Jul 2013
Bacterin’s OsteoSelect(R) DBM Putty Approved for Spinal Fusion Applications
Bacterin’s OsteoSelect(R) DBM Putty Approved for Spinal Fusion Applications
HSMN NewsFeed - 8 Jul 2013
Market Access Granted in Italy for Aggressive non-Hodgkin Lymphoma Treatment, PIXUVRI(R) (pixantrone)
Market Access Granted in Italy for Aggressive non-Hodgkin Lymphoma Treatment, PIXUVRI(R) (pixantrone)
HSMN NewsFeed - 19 Apr 2013
BioTime Enters into Worldwide License Agreement with UCLA to Develop Therapy for the Treatment of Stroke
BioTime Enters into Worldwide License Agreement with UCLA to Develop Therapy for the Treatment of Stroke
HSMN NewsFeed - 15 Apr 2013
David A. Dodd Appointed President & Chief Executive Officer of Aeterna Zentaris Inc.
David A. Dodd Appointed President & Chief Executive Officer of Aeterna Zentaris Inc.
HSMN NewsFeed - 28 Mar 2013
Stem Cell Therapeutics Provides Corporate Update on Acquisitions and Financing
Stem Cell Therapeutics Provides Corporate Update on Acquisitions and Financing
HSMN NewsFeed - 27 Mar 2013
Bioheart's Appeals to the FDA for Compassionate Use Designation to Save Lives
Bioheart's Appeals to the FDA for Compassionate Use Designation to Save Lives
HSMN NewsFeed - 14 Mar 2013
Spectrum Pharmaceuticals Gains Rights to Pivotal-Stage Captisol-Enabled(R) Melphalan
Spectrum Pharmaceuticals Gains Rights to Pivotal-Stage Captisol-Enabled(R) Melphalan
HSMN NewsFeed - 12 Mar 2013
TiGenix to Obtain National Reimbursement in Spain for Its Innovative Cartilage Therapy ChondroCelect(R)
TiGenix to Obtain National Reimbursement in Spain for Its Innovative Cartilage Therapy ChondroCelect(R)
HSMN NewsFeed - 26 Feb 2013
Cytori Appoints Dr. Steven Kesten as Executive Vice President and Chief Medical Officer
Cytori Appoints Dr. Steven Kesten as Executive Vice President and Chief Medical Officer
HSMN NewsFeed - 21 Feb 2013
Gentium Provides Update on the Review of Defibrotide Marketing Authorization
Gentium Provides Update on the Review of Defibrotide Marketing Authorization
HSMN NewsFeed - 13 Feb 2013
Cellerant Appoints William Reed, M.D., as Vice President, Clinical Development
Cellerant Appoints William Reed, M.D., as Vice President, Clinical Development
HSMN NewsFeed - 4 Feb 2013
Stem Cell Therapeutics Announces Agreement With Trillium Therapeutics Inc. for Merger
Stem Cell Therapeutics Announces Agreement With Trillium Therapeutics Inc. for Merger
HSMN NewsFeed - 28 Jan 2013
BrainStorm Cell Therapeutics Appoints Alon Natanson as Chief Executive Officer
BrainStorm Cell Therapeutics Appoints Alon Natanson as Chief Executive Officer
HSMN NewsFeed - 22 Jan 2013
Tau Therapeutics Hires Chief Medical Officer and VP of Operations and Strategy
Tau Therapeutics Hires Chief Medical Officer and VP of Operations and Strategy
HSMN NewsFeed - 3 Dec 2012
ImmunoCellular Therapeutics Appoints Andrew Gengos as Chief Executive Officer
ImmunoCellular Therapeutics Appoints Andrew Gengos as Chief Executive Officer
HSMN NewsFeed - 29 Nov 2012
Cytomedix Announces CE Mark Approval for Angel(R) cPRP System for Processing Blood and Bone Marrow Aspirate
Cytomedix Announces CE Mark Approval for Angel(R) cPRP System for Processing Blood and Bone Marrow Aspirate
HSMN NewsFeed - 14 Nov 2012
StemGenex(TM) on the Forefront of Adult Stem Cell-Based Therapy for Alzheimer's
StemGenex(TM) on the Forefront of Adult Stem Cell-Based Therapy for Alzheimer's
HSMN NewsFeed - 8 Nov 2012
Angel(R) cPRP System Granted FDA 510(K) Clearance for Processing Blood and Bone Marrow Aspirate
Angel(R) cPRP System Granted FDA 510(K) Clearance for Processing Blood and Bone Marrow Aspirate
HSMN NewsFeed - 1 Nov 2012
BioTime Subsidiary OrthoCyte Corporation Announces the Appointment of Francois Binette as Vice President
BioTime Subsidiary OrthoCyte Corporation Announces the Appointment of Francois Binette as Vice President
HSMN NewsFeed - 26 Oct 2012
Teva Receives Approval For SYNRIBO(TM) (Omacetaxine Mepesuccinate) for Injection
Teva Receives Approval For SYNRIBO(TM) (Omacetaxine Mepesuccinate) for Injection
HSMN NewsFeed - 15 Oct 2012
Fate Therapeutics Appoints Christian Weyer As President And Chief Executive Officer
Fate Therapeutics Appoints Christian Weyer As President And Chief Executive Officer
HSMN NewsFeed - 25 Sep 2012
Life Technologies Launches Pervenio(TM) Lung RS, a Risk Stratification Test for Early Stage Lung Cancer
Life Technologies Launches Pervenio(TM) Lung RS, a Risk Stratification Test for Early Stage Lung Cancer
HSMN NewsFeed - 5 Sep 2012
Third Critically Ill Patient Successfully Treated With Pluristem's PLX Cells Under Compassionate Use
Third Critically Ill Patient Successfully Treated With Pluristem's PLX Cells Under Compassionate Use
HSMN NewsFeed - 6 Aug 2012
Cytomedix Announces Medicare Coverage for Autologous PRP Gel in Chronic Wound Care
Cytomedix Announces Medicare Coverage for Autologous PRP Gel in Chronic Wound Care
HSMN NewsFeed - 26 Jun 2012
Discgenics Announces the Appointment of Robert M. Wynalek as Chief Operating and Commercialization Officer
Discgenics Announces the Appointment of Robert M. Wynalek as Chief Operating and Commercialization Officer
HSMN NewsFeed - 31 May 2012
Cell Therapeutics' Pixuvri(R) Phase 3 Clinical Trial Results Published in The Lancet Oncology
Cell Therapeutics' Pixuvri(R) Phase 3 Clinical Trial Results Published in The Lancet Oncology
HSMN NewsFeed - 11 May 2012
InVivo Therapeutics Adds Senior Leadership in Manufacturing and Cell Research
InVivo Therapeutics Adds Senior Leadership in Manufacturing and Cell Research
HSMN NewsFeed - 9 May 2012
Cardio3 BioSciences Announces CE Marking for its C-Cath(R) Injection Catheter
Cardio3 BioSciences Announces CE Marking for its C-Cath(R) Injection Catheter
HSMN NewsFeed - 19 Mar 2012
Genmab Provides Update on Ofatumumab Phase III Head to Head Study in DLBCL
Genmab Provides Update on Ofatumumab Phase III Head to Head Study in DLBCL
HSMN NewsFeed - 15 Mar 2012
TetraLogic Pharmaceuticals Appoints C. Glenn Begley as Senior Vice President Research and Development
TetraLogic Pharmaceuticals Appoints C. Glenn Begley as Senior Vice President Research and Development
HSMN NewsFeed - 8 Mar 2012
The Radiosurgery Society(TM) Completes its First Scientific Meeting as an Independent Society
The Radiosurgery Society(TM) Completes its First Scientific Meeting as an Independent Society
HSMN NewsFeed - 28 Feb 2012
Baxter Initiates Phase III Adult Stem Cell Clinical Trial for Chronic Cardiac Condition
Baxter Initiates Phase III Adult Stem Cell Clinical Trial for Chronic Cardiac Condition
HSMN NewsFeed - 28 Feb 2012
Bioheart Announces University of Miami as Clinical Site for ANGEL Trial of LipiCell(TM)
Bioheart Announces University of Miami as Clinical Site for ANGEL Trial of LipiCell(TM)
HSMN NewsFeed - 14 Feb 2012
Bioheart Acquires Exclusive Rights to Ageless Regenerative Institute's Adipose Cell Technology
Bioheart Acquires Exclusive Rights to Ageless Regenerative Institute's Adipose Cell Technology
Additional items found! 494

Members Archive contains
494 additional stories matching:
stem cell
(Password required)
stem cell
(Password required)